Zacks.com on MSN11h
Biotech Stock Roundup: GILD, NUVL Stocks Surge on Study Data, MRNA Down on Updates
It was a busy week for the biotech sector with a lot of important data readouts at the European Society for Medical Oncology ...
NoGarlicNoOnions1d
Nasal Scope Procedure Explained - What to Expect During a Nose Scope?
During a nasal endoscopy, the health care provider tries to look inside your nose or the opening of the sinus passage to ...
MedPage Today2d
First Drug OK'd for Chronic Rhinosinusitis With Nasal Polyps in Adolescents
The FDA broadened dupilumab's (Dupixent) approval as an add-on maintenance treatment for chronic rhinosinusitis with nasal ...
Regeneron, SNY Win FDA Approval for a Broader Dupixent Label
REGN gets FDA nod for Dupixent for a broader population for the indication of chronic rhinosinusitis with nasal polyps.
Regeneron’s Dupixent approved as first adolescent CRSwNP treatment
The safety profile of Dupixent in adolescents with moderate-to-severe asthma contributed to the FDA's decision.
Monthly Prescribing Reference6d
Dupixent Approval Expanded to Include Adolescent Patients With CRSwNP
The Food and Drug Administration (FDA) has expanded the approval of Dupixent ® (dupilumab) to include add-on maintenance treatment of adolescent patients aged 12 to 17 years with inadequately ...